ライフサイエンスコーパス: main pancreatic duct

1 ere accompanied by reverse-Z type meandering main pancreatic duct.

2 of significant disruption or stenosis of the main pancreatic duct.

3 fistula, especially when performed near the main pancreatic duct.

4 l, intercalated, intracalated ducts, and the main pancreatic duct.

5 dder, cystic duct (CD), common bile duct and main pancreatic duct and their courses and interactions

6 Increased body mass index, small main pancreatic duct, and soft pancreatic texture are we

7 les, thickening of the wall, dilation of the main pancreatic duct, and tumor markers.

8 atients with chronic pancreatitis, a dilated main pancreatic duct, and who only recently started usin

9 r deletion of p120 catenin displayed dilated main pancreatic ducts, chronic pancreatitis, acinar to d

10 Additionally, diameters of main pancreatic duct, common bile duct and angles betwee

11 ic duct, common bile duct and angles between main pancreatic duct-common bile duct and cystic duct-co

12 graphic features such as solid component and main pancreatic duct diameter >=10 mm also differed (sol

13 The study also found a correlation between main pancreatic duct diameter and age, where larger diam

14 IPMN type and main pancreatic duct diameter were significant predictor

15 uncinate process tumors and proximity to the main pancreatic duct did not demonstrate inferior postop

16 nce of enhanced solid component (P = 0.014), main pancreatic duct dilatation of more than 5 mm (P < 0

17 g high-risk features on initial imaging (eg, main pancreatic duct dilatation, a solid component, or m

18 rolled for Das-1 in multivariate regression, main pancreatic duct dilation >5 mm (odds ratio, 14.98;

19 % confidence interval, 2.63-108; P < .0012), main pancreatic duct dilation >=1 cm (odds ratio, 47.9;

20 ), thick walls (14.4 vs 5.6%, p = 0.001) and main pancreatic duct dilation (13.4 vs 5.6%, p = 0.004)

21 ular cysts of the pancreas and a non-dilated main pancreatic duct (<5 mm).

22 such as an ansa pancreatica and a meandering main pancreatic duct (MMPD).

23 nes list symptoms, cyst size >30 mm, dilated main pancreatic duct (MPD) >6 mm, mural nodule (MN) and

24 ficant correlation between the length of the main pancreatic duct (MPD) and the intraglandular portio

25 treatment in main-duct IPMN patients with a main pancreatic duct (MPD) diameter of >/=10 mm.

26 (mixed IPMNs) of the pancreatic system is a main pancreatic duct (MPD) diameter of 5.0 mm or greater

27 n 103 patients with chronic pancreatitis and main pancreatic duct (MPD) dilatation (>7 mm).

28 S and GNAS mutant status) and with available main pancreatic duct (MPD) size data were included.

29 ression was defined as a new IPMN, increased main pancreatic duct (MPD) size, and increased size of a

30 The main pancreatic duct (MPD) was evaluated in the head of

31 ancreas-specific morbidity and injury to the main pancreatic duct (MPD) was noted.

32 ncreatic phase; 2D curved reformations along main pancreatic duct (MPD) were generated.

33 The high-risk of malignancy associated with main pancreatic duct (MPD)-involved intraductal papillar

34 33) revealed histological involvement of the main pancreatic duct not evident in preoperative imaging

35 atic head, intractable abdominal pain, and a main pancreatic duct obstruction or stricture resulting

36 than 4 cm (P < 0.001), presence of a dilated main pancreatic duct of over 4 mm (P < 0.001), histopath

37 specimens of 15 patients with IPMT (dilated main pancreatic duct or branch ducts with mucin overprod

38 sms of mucin-producing cells, arising in the main pancreatic duct or its branches.

39 body mass index, RPV, SAT/VAT area, SM area, main pancreatic duct size, and pancreatic gland texture

40 DVICE 5: When ERCP is pursued, small (<=5mm) main pancreatic duct stones can be treated with pancreat

41 fective for treating symptoms and remodeling main pancreatic duct strictures.

42 s) are gland-like outpouches budding off the main pancreatic ducts that function as a progenitor nich

43 to distinguish nonneoplastic from neoplastic main pancreatic duct tissue.

44 In cats, the main pancreatic duct was partially obstructed and the an

45 copic US, and diffuse irregular narrowing of main pancreatic duct, with associated multiple biliary s